Concepedia

Publication | Closed Access

A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195

DOI

62

Citations

26

References

2015

Year

Bernhard J. Eigl, Scott North, Eric Winquist, Daygen L. Finch, Lori Wood, Srikala S. Sridhar, Jean Powers, Jennifer Good, Mansi Sharma, Jeremy A. Squire,
Investigational New Drugs

References

YearCitations

Page 1